These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 38773226)

  • 1. Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction.
    Ding T; Shang Z; Zhao H; Song R; Xiong J; He C; Liu D; Yi B
    Sci Rep; 2024 May; 14(1):11525. PubMed ID: 38773226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the molecular subtypes and signatures to predict the prognosis, biological functions, and therapeutic response based on the anoikis-related genes in colorectal cancer.
    Zhai X; Chen B; Hu H; Deng Y; Chen Y; Hong Y; Ren X; Jiang C
    Cancer Med; 2024 May; 13(10):e7315. PubMed ID: 38785271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an anoikis-related gene signature and prognostic model for predicting the tumor microenvironment and response to immunotherapy in colorectal cancer.
    Li C; Weng J; Yang L; Gong H; Liu Z
    Front Immunol; 2024; 15():1378305. PubMed ID: 38779664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel Anoikis and immune-related genes marked prognostic signature for colorectal cancer.
    Cai Z; Zhou F
    Medicine (Baltimore); 2022 Nov; 101(46):e31127. PubMed ID: 36401385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of basement membrane-related gene based on single-cell and bulk RNA sequencing data to predict prognosis and evaluate immune characteristics in colorectal cancer.
    Han J; Wang Q; Li S; Yang J; Qiu Z; Fu W
    Environ Toxicol; 2024 Jun; 39(6):3367-3380. PubMed ID: 38445432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a five-gene signature with prognostic value in colorectal cancer.
    Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
    J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering anoikis resistance and identifying prognostic biomarkers in clear cell renal cell carcinoma epithelial cells.
    Li J; Cao Q; Tong M
    Sci Rep; 2024 May; 14(1):12044. PubMed ID: 38802480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
    Gao X; Yang J
    DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Cell RNA Sequencing Reveals the Role of Epithelial Cell Marker Genes in Predicting the Prognosis of Colorectal Cancer Patients.
    Shen KY; Chen BY; Gao WC
    Dis Markers; 2022; 2022():8347125. PubMed ID: 35968507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel anoikis-related risk model predicts prognosis in patients with colorectal cancer and responses to different immunotherapy strategies.
    Yang L; Xu F
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10879-10892. PubMed ID: 37318595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a gene signature associated with anoikis to evaluate the prognosis and immune infiltration in patients with colorectal cancer.
    Wen H; Ni X; Qian S; Abdul S; Lv H; Chen Y
    Transl Cancer Res; 2024 Apr; 13(4):1904-1923. PubMed ID: 38737694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
    Lin D; Fan W; Zhang R; Zhao E; Li P; Zhou W; Peng J; Li L
    J Transl Med; 2021 Jun; 19(1):279. PubMed ID: 34193202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
    Zhang X; Wen Z; Wang Q; Ren L; Zhao S
    Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer.
    Xiao Y; Zhou H; Chen Y; Liu L; Wu Q; Li H; Lin P; Li J; Wu J; Tang L
    Front Genet; 2023; 14():1186862. PubMed ID: 37323657
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer.
    Huang A; Sun Z; Hong H; Yang Y; Chen J; Gao Z; Gu J
    J Transl Med; 2024 Jun; 22(1):587. PubMed ID: 38902737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.